Blog

Appian (NASDAQ: APPN) and Shopify (NYSE: SHOP) operate in different markets, but they both help clients compete in an increasingly digital world. That has translated into big gains for shareholders

AstraZeneca (NASDAQ: AZN) announced its first interim efficacy results for its COVID-19 vaccine last week. But the National Institutes of Health (NIH) quickly released a statement that seemed to

The financial industry has seen rapid innovations in the past decade. The merger of finance and technology has caused an explosion of life-changing fintech companies. During this same time, we've

Did you receive your third round of stimulus money but don't need it for basic expenses? Saving it and investing for later is a smart move. If you have at least a few years to wait (the more, the

Abiomed (NASDAQ: ABMD) and Guardant Health (NASDAQ: GH) both sport market caps just north of $13 billion, but these companies represent very different ways to invest in healthcare stocks for the

Buying dividend stocks can be a great way to ensure you have some recurring income flowing into your portfolio, without needing to cash out of your existing investments. The stock market has been

The market has kept investors on their toes over the past 12 months, as it marked record lows in March 2020 followed by a sharp recovery to reach record highs. And since the start of 2021, new

Price didn't matter in 2020, as investors bet on the fastest-growing companies. It wasn't so long ago that paying 20 times annual sales for a money-losing software company seemed crazy.

After a

At this point, a lot of people have received a $1,400 stimulus check as part of the $1.9 trillion American Rescue Plan. And if you haven't seen your money yet, don't worry -- that check could still

In times like these, investing is exciting. Some stocks are up several hundred percent since their March 2020 lows, and it seems like the same high-flying growth stocks are in everyone's portfolios

The market never likes it when a company engages in a bidding war. Case in point: the massive 35% haircut laser photonics-maker II-VI (NASDAQ: IIVI) has taken since Feb. 11. That's when it hit

Much has been made of chimeric antigen receptor T-cell therapy (CAR T-cell therapy) over the past four to five years. And while the therapy is certainly impressive, it typically only applies to

There are several large players in the world of animal health, including Idexx Labs and Zoetis, but Heska (NASDAQ: HSKA), a much smaller competitor, has outperformed its larger peers in terms of

Finding amazing stocks under $10 can be tricky. Last year, I hit the jackpot with Novavax (NASDAQ: NVAX), buying shares at $4, and then riding the stock all the way up to $300 a share earlier this

We all invest for different reasons, and we all have different goals, metrics, and ways to narrow down our research in the process of buying a new stock. Like most investors, when I add a new

More than one year into the coronavirus pandemic, hope is on the horizon. With three different coronavirus vaccines authorized for emergency use in the U.S. and the rate of vaccine distribution

Canopy Growth (NASDAQ: CGC) enjoys some of the best name recognition in the cannabis industry. A lot of the credit certainly goes to former CEO Bruce Linton, who did a great job of not just growing

Pfizer (NYSE: PFE) worked with its German partner BioNTech (NASDAQ: BNTX) to develop and launch the world's first COVID-19 vaccine. But now the big drugmaker says that it plans to develop future

When you think of COVID-19 vaccines, shots probably come to mind. However, a small biotech, Vaxart (NASDAQ: VXRT), is developing an oral COVID-19 vaccine candidate. In this Motley Fool Live video

For a majority of investors, volatility isn't something they look forward to. Then again, millennials aren't like a majority of investors.

In the wake of historic volatility over the past year and

With the first calendar quarter of 2021 coming to a close yesterday, many companies' accounting departments are scrambling to wrap up their quarterly financials. But we won't have to wait until

On Tuesday night, the New York State Senate passed a bill to legalize recreational marijuana. The following day, Gov. Andrew Cuomo signed the bill into law. These moves happened quickly, just days

This isn't an April Fools' Day joke. Moderna (NASDAQ: MRNA) could be viewed as a value stock. Seriously.

I know what you're probably thinking: How can a stock with a market cap of over $51 billion

In this Motley Fool Live video recorded on March 26, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss how Pfizer (NYSE: PFE), Moderna (NASDAQ:

In this Motley Fool Live video recorded on March 26, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss which company may receive Emergency Use